TNF and rheumatoid arthritis: Therapies used with less frequency were anti-TNF treatment for three women (1.5%) until the second term of pregnancy (certolizumab for two women with RA and etanercept for one woman with SpA) and corticosteroids (usually doses of ≤ 5 mg of prednisone) for 30 (15.2%) women.